ErinM.(Ort)BertinoMD(She/Her)

Oncology • Columbus, OH

Hematologic Oncology, Thoracic Cancer

Physician

Join to view full profile

Dr. Bertino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bertino's full profile

Already have an account?

Office
300 W 10th Ave
2nd Floor
Columbus, OH 43210
Phone+1 614-293-6786

Fax+1 614-293-1470
Is this information wrong?

Education & Training

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
Ohio State University HospitalResidency, Internal Medicine, 2004 - 2007
Northeast Ohio Medical UniversityClass of 2004

Certifications & Licensure

OH State Medical License 2004 - 2026
NC State Medical License 2021 - 2022
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer Start of enrollment: 2011 Feb 10
Completed
Phase 1
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor Start of enrollment: 2012 Dec 01
Completed
Phase 1
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
Active, not recruiting
Phase 2
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy Start of enrollment: 2020 Apr 16
Active, not recruiting
Phase 2
Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer Start of enrollment: 2020 Jun 17
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

CRE24-044: Response to Dabrafenib and Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Metastatic Non-Small Cell Lung Cancer.
John Sharp, Daniel Jones, Julia Rotow, Panos Fidias, Erin Bertino, Dwight Owen> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer.
John A Sharp, Daniel Jones, Julia K Rotow, Panos M Fidias, Erin Bertino, Dwight H Owen> ;Journal of the National Comprehensive Cancer Network. 2024 Mar 13
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.
He, K., Terence M Williams, Eric Miller, Meng Welliver, Jeremy Brownstein, Gregory Otterson, Dwight Owen, Karl Haglund, Peter Shields, Erin Bertino, Carolyn Presley, K...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 20
Improving Access to Early Palliative Care Delivery for Patients With an Advanced Thoracic Malignancy Through an Embedded Oncopalliative Clinic Model.
Julia L Agne, Erin M Bertino, Kelly Gast, Madison M Grogan, Sarah Janse, Jason Benedict, Carolyn J Presley> ;JCO Oncology Practice. 2023 Sep 1
3 citations
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya, Madison Grogan, Sandip Patel, Karthik Chakravarthy, Abdul Miah, Daniel Spakowicz, Ga...> ;Cancer Immunology, Immunotherapy. 2023 Jul 1
2 citations
Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancy.
Erin M Bertino, Madison M Grogan, Jason A Benedict, Julia L Agne, Sarah Janse, Christine Eastep, Diana Sullivan, Kelly C Gast, Michelle J Naughton, Carolyn J Presley> ;Supportive Care in Cancer. 2023 Feb 14
4 citations
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival.
Abdul Miah, Gabriel Tinoco, Songzhu Zhao, Lai Wei, Andrew Johns, Sandip Patel, Mingjia Li, Madison Grogan, Gabrielle Lopez, Marium Husain, Rebecca Hoyd, Khalid Mumtaz,...> ;Journal of Cancer Research and Clinical Oncology. 2023 May 1
11 citations
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.
Laura Q M Chow, Fabrice Barlesi, Erin M Bertino, Martin J van den Bent, Heather A Wakelee, Patrick Y Wen, Chao-Hua Chiu, Sergey Orlov, Rita Chiari, Margarita Majem, Ma...> ;Clinical Cancer Research. 2022 Jun 13
11 citations
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
Yizhen Guo, Lai Wei, Sandip H Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li, Tyler Haddad, Andrew Johns, Latha P Ganesan, Yiping Yang, Daniel J Spakowicz, Peter G...> ;Clinical Lung Cancer. 2022 Jun 1
1 citations
Podcast on the Management of Adverse Events Associated with Lorlatinib.
Todd M Bauer, Erin M Bertino> ;Advances in Therapy. 2022 Apr 1
1 citations
Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an explor...
Thomas E Stinchcombe, Xiaofei Wang, Robert C Doebele, Leylah M Drusbosky, David E Gerber, Leora Horn, Erin M Bertino, Geoff Liu, Liza C Villaruz, D Ross Camidge> ;Lung Cancer. 2022 Mar 1
5 citations
Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy.
Kelly C Gast, Jason A Benedict, Madison Grogan, Sarah Janse, Maureen Saphire, Pooja Kumar, Erin M Bertino, Julia L Agne, Carolyn J Presley> ;Frontiers in Oncology. 2022 Jan 1
9 citations
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler Haddad, Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan, Gabriella Lopez, Abdul Miah, Lai Wei, Gabriel Tinoco, Brian Riesenberg, Zihai Li...> ;Cancer Immunology, Immunotherapy. 2021 Oct 7
2 citations
Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care.
Pooja S. Kumar, Maureen L. Saphire, Madison Grogan, Jason A. Benedict, Sarah Janse, Julia L Agne, Erin M. Bertino, Carolyn J Presley> ;Journal of Pain & Palliative Care Pharmacotherapy. 2021 May 19
7 citations
Too Many Appointments: Assessing Provider and Nursing Perception of Barriers to Referral for Outpatient Palliative Care.
Julia L. Agne, Erin M. Bertino, Madison Grogan, Jason Benedict, Sarah Janse, Michelle J. Naughton, Christine Eastep, Michael Callahan, Carolyn J Presley> ;Palliative Medicine Reports. 2021 May 17
39 citations
Advances in epigenetic therapeutics with focus on solid tumors.
Ning Jin, Tiffany L. George, Gregory A. Otterson, Claire F. Verschraegen, Haitao Wen, David P. Carbone, James G. Herman, Erin M. Bertino, Kai He> ;Clinical Epigenetics. 2021 Apr 20
20 citations
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shiri...> ;Journal of the National Comprehensive Cancer Network. 2021 Apr 20
17 citations
Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903)
Erin M. Bertino, Ryan D. Gentzler, Sarah E. Clifford, Jill M. Kolesar, Alona Muzikansky, Eric B. Haura, Zofia Piotrowska, D. Ross Camidge, Thomas E. Stinchcombe, Chris...> ;Clinical Cancer Research. 2021 Mar 15
7 citations
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Jean G. Bustamante Alvarez, Sarah Janse, Dwight H. Owen, Stephanie Kiourtsis, Erin M. Bertino, Kai He, David P. Carbone, Gregory A. Otterson> ;Clinical Lung Cancer. 2021 Jul 1
11 citations
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer
Mingjia Li, Daniel Spakowicz, Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan, Abdul Miah, Marium Husain, Kai He, Erin M. Bertino, Peter G. Shields, Lai We...> ;Cancer Immunology, Immunotherapy. 2020 Jul 29
37 citations
Second cancer incidence in CLL patients receiving BTK inhibitors.
David A. Bond, Ying Huang, James L. Fisher, Amy S. Ruppert, Dwight H. Owen, Erin M. Bertino, Kerry A Rogers, Seema A. Bhat, Michael R. Grever, Samantha Jaglowski, Kami...> ;Leukemia. 2020 Jul 23
29 citations
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Respon...
Erin L. Schenk, Grace K. Dy, Marie Christine Aubry, Angelina D. Tan, Shaker R. Dakhil, Bradley A. Sachs, Jorge Nieva, Erin M. Bertino, Christine L. Hann, Steven E. Sch...> ;Journal of Thoracic Oncology. 2020 Jan 1
78 citations
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Random...
Thomas E. Stinchcombe, Pasi A. Jänne, Xiaofei Wang, Erin M. Bertino, Jared Weiss, Lyudmila Bazhenova, Lin Gu, Christie J. Lau, Cloud P. Paweletz, Anthony J. Jaslowski,...> ;JAMA Oncology. 2019 Oct 1
75 citations
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
Mingjia Li, Daniel Spakowicz, Jarred Burkart, Sandip H. Patel, Marium Husain, Kai He, Erin M. Bertino, Peter G. Shields, David P. Carbone, Claire F. Verschraegen, Caro...> ;Journal of Cancer Research and Clinical Oncology. 2019 Jul 31
7 citations
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer.
Dwight H. Owen, Terence M. Williams, Erin M. Bertino, Xiaokui Mo, Amy Webb, Catherine Schweitzer, Tom Liu, Sameek Roychowdhury, Cynthia Timmers, Gregory A. Otterson> ;Lung Cancer. 2019 Jun 17
Join now to see all

Journal Articles

Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database
Kai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central